Celerion R&D Portfolio_Property for Sale
Celerion R&D Portfolio_Property for Sale
Various locations

Celerion R&D Portfolio

Portfolio description

Jones Lang LaSalle America, Inc. ("JLL") is pleased to offer for sale the Celerion R&D Portfolio, which comprises two mission-critical facilities located in Tempe, AZ and Lincoln, NE. The Portfolio is 100% master leased to Celerion, Inc. ("Tenant") with 5.5 years of absolute NNN lease term remaining that includes 2.0% annual rent increases and four 5-year renewal options. Celerion is a global contract research organization that specializes in complex clinical services for pharmaceutical, biotechnology, and generic drug companies.


In 2015, Celerion affirmed its long-term commitment to the Properties by executing a 15-year sale-leaseback. These mission-critical Properties are Celerion’s only clinical research facilities in North America, and two of three globally.


  • Tempe, AZ is a state-of-the-art R&D facility that was purpose-built for Celerion in 2006.
  • Lincoln, NE represents Celerion's headquarters and R&D facility for over 50 years. Notably, Celerion has a strategic partnership with its neighboring hospital campus and offers pharma and biotech companies the opportunity to conduct early-stage clinical studies in a hospital setting.


Both Properties feature hospital-grade finishes, emergency generators, and specialized storage for clinical samples. These Properties undergo constant and rigorous regulatory inspections and are essential for Celerion's industry-leading drug trial services.

...

Attributes

Occupancy
100%
Lease type
Absolute Triple Net
Building area gross
233,565 sf
Remaining lease term
5.5 years
Celerion R&D Portfolio (2 Properties)
Celerion R&D Portfolio (2 Properties)

Media

Investment Highlights

  • Leading clinical research organization that specializes in complex end-to-end early-stage clinical trial and bioanalytical services.
  • 91-year operating history serving a diverse customer base across pharma and biotech industries.
  • 5.5-year absolute NNN master lease with 2.0% annual rent increases and zero landlord expense responsibilities.
  • In-place rents are below market, affording investors an attractive basis and a high likelihood of renewal.
  • Celerion's only clinical research facilities in North America, and two of only three globally.
  • Mission-critical facilities with high tenant investment that would be incredibly costly and challenging to replicate elsewhere.
  • Strategically located next to leading hospital campuses and healthcare systems for long-term partnerships in clinical research.
Celerion R&D Portfolio 4_Property for Sale
Celerion R&D Portfolio 4_Property for Sale

Contact brokers

Similar properties

View moreChevron Right
Do you have any questions? visit our FAQ page
View FAQ PageArrow Right
JLL can help you finance and manage your portfolio. Email us today to see how we can help achieve your ambitions.
Last updated
6 Nov 2024